NLRP3 and colitis: Schisandrin B can not only relieve intestinal inflammation, but also suppress the leucine-rich repeat, pyrin domain-containing 3 (NLRP3) inflammasome, and nucleotide-binding oligomerization domain in vivo and vitro model of colitis.